Clinical Trials Directory

Trials / Terminated

TerminatedNCT00535821

Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock

A Multi-center Randomized Comparison of a Minimally-invasive Cardiovascular Hemodynamic Optimization (MiCHO) Protocol Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock Patients Presenting to the Emergency Department

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Early intervention in the treatment of septic shock, including early goal-directed therapy (EGDT) in the first 6 hours of disease presentation, has been shown to significantly decrease mortality. However, this approach requires invasive hemodynamic monitoring, thus limiting its widespread application in the emergency department setting. A minimally invasive protocol utilizing esophageal Doppler monitoring (EDM) may be of benefit and practical if it is shown to result in similar outcome as EGDT.

Conditions

Interventions

TypeNameDescription
DEVICEEsophageal Doppler monitoring - CardioQ, Deltex Inc6-hour hemodynamic optimization of severe sepsis or septic shock guided by EDM
DEVICECentral line with CVP and continuous ScvO2 monitoring6-hour hemodynamic optimization of severe sepsis or septic shock guided by CVP and ScvO2 monitoring

Timeline

Start date
2007-06-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2007-09-26
Last updated
2014-06-25
Results posted
2014-06-25

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00535821. Inclusion in this directory is not an endorsement.